ARCHIVES

Collaborative Drug Development Groups Clear BSC Overview, Natural Products RFA To Proceed

This article is from The Cancer Letter archive.

Vol. 14 No. 24 | June 10, 1988

Download PDF Visit The Full Archive

Related Articles

Komen Officials Say Charity is Stabilizing Despite 22 Percent Drop in Contributions

January 24, 2014

FDA Approves Generic Capecitabine

September 20, 2013

Facing Congressional Criticism, NIH Starts Review of Extramural Conflict Policies.

June 13, 2008

Organ Systems Program Finally Loses a Couple, But Gets OK for Breast Cancer Risk Study RFA

June 20, 1986

“What Is Good For NCI Is Good For NIH,” Broder Says In Address

January 13, 1995

Report Finds NIH Not At Fault in Case Of P-32 Ingestion

September 26, 1997